{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:16Z","timestamp":1786975636425,"version":"build-2736575974"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Enrolling racially and ethnically diverse pediatric research participants is critical to ensuring equitable access to health advances and generalizability of research findings.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To examine the reporting of race and ethnicity for National Institutes of Health (NIH)\u2013funded pediatric clinical trials and to assess the representation of pediatric participants from different racial and ethnic groups compared with distributions in the US population.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study included NIH-funded pediatric (ages 0-17 years) trials with grant funding completed between January 1, 2017, and December 31, 2019, and trial results reported as of June 30, 2022.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n National Institutes of Health policies and guidance statements on the reporting of race and ethnicity of participants in NIH-funded clinical trials.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was reporting of participant race and ethnicity for NIH-funded pediatric clinical trials in publications and ClinicalTrials.gov.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n There were 363 NIH-funded pediatric trials included in the analysis. Reporting of race and ethnicity data was similar in publications and ClinicalTrials.gov, with 90.3% (167 of 185) of publications and 93.9% (77 of 82) of ClinicalTrial.gov reports providing data on race and\/or ethnicity. Among the 160 publications reporting race, there were 43 different race classifications, with only 3 publications (1.9%) using the NIH-required categories. By contrast, in ClinicalTrials.gov, 61 reports (79.2%) provided participant race and ethnicity using the NIH-specified categories (\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). There was racially and ethnically diverse enrollment of pediatric participants, with overrepresentation of racial and ethnic minority groups compared with the US population.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cross-sectional study of NIH-funded pediatric clinical trials found high rates of reporting of participant race and ethnicity, with diverse representation of trial participants. These findings suggest that the NIH is meeting its directive of ensuring diverse participant enrollment in the research it supports.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.31316","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:35:26Z","timestamp":1693395326000},"page":"e2331316","source":"Crossref","is-referenced-by-count":31,"title":["Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health\u2013Funded Pediatric Clinical Trials"],"prefix":"10.1001","volume":"6","author":[{"given":"Lois K.","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston, Massachusetts"},{"name":"Office of Health Equity and Inclusion, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Narang","sequence":"additional","affiliation":[{"name":"Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Rees","sequence":"additional","affiliation":[{"name":"Division of Pediatric Emergency Medicine, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi R.","family":"Thiagarajan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston, Massachusetts"},{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Melvin","sequence":"additional","affiliation":[{"name":"Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston, Massachusetts"},{"name":"Office of Health Equity and Inclusion, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Ward","sequence":"additional","affiliation":[{"name":"Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston, Massachusetts"},{"name":"Office of Health Equity and Inclusion, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Radiology, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence T.","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"},{"name":"Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"issue":"10","key":"zoi230911r2","first-page":"1","article-title":"Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.","volume":"94","author":"Burroughs","year":"2002","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"zoi230911r3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3138\/ijfab.1.2.5","article-title":"The second wave: toward responsible inclusion of pregnant women in research.","volume":"1","author":"Lyerly","year":"2008","journal-title":"Int J Fem Approaches Bioeth"},{"issue":"1","key":"zoi230911r5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057998","article-title":"Eliminating race-based medicine.","volume":"150","author":"Wright","year":"2022","journal-title":"Pediatrics"},{"issue":"210","key":"zoi230911r10","first-page":"58782","article-title":"Revisions to the standards for the classification of federal data on race and ethnicity.","volume":"62","year":"1997","journal-title":"Fed Regist"},{"issue":"4","key":"zoi230911r11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058552","article-title":"Race and ethnicity reporting and representation in pediatric clinical trials.","volume":"151","author":"Brewster","year":"2023","journal-title":"Pediatrics"},{"issue":"5","key":"zoi230911r12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-042903","article-title":"Racial and ethnic diversity in studies funded under the Best Pharmaceuticals for Children Act.","volume":"147","author":"Abdel-Rahman","year":"2021","journal-title":"Pediatrics"},{"issue":"8","key":"zoi230911r13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/pbc.25472","article-title":"Participation in pediatric oncology research protocols: racial\/ethnic, language and age-based disparities.","volume":"62","author":"Aristizabal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"zoi230911r14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230824","article-title":"Assessment of enrollment characteristics for Children\u2019s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.","volume":"15","author":"Faulk","year":"2020","journal-title":"PLoS One"},{"issue":"21","key":"zoi230911r15","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1002\/cam4.v10.21","article-title":"Patterns of National Cancer Institute\u2013sponsored clinical trial enrollment in black adolescents and young adults.","volume":"10","author":"Roth","year":"2021","journal-title":"Cancer Med"},{"issue":"5","key":"zoi230911r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0142","article-title":"Reporting of participant race and ethnicity in published US pediatric clinical trials from 2011 to 2020.","volume":"176","author":"Rees","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"7","key":"zoi230911r18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jama.2022.24025","article-title":"Dissemination of the results of pediatric clinical trials funded by the US National Institutes of Health.","volume":"329","author":"Rees","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"zoi230911r22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1001\/jama.2015.8761","article-title":"Characteristics of clinical studies conducted over the total product life cycle of high-risk therapeutic medical devices receiving FDA premarket approval in 2010 and 2011.","volume":"314","author":"Rathi","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"zoi230911r23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.2013.282034","article-title":"Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.","volume":"311","author":"Downing","year":"2014","journal-title":"JAMA"},{"issue":"25","key":"zoi230911r27","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMp2201433","article-title":"A data infrastructure for clinical trial diversity.","volume":"386","author":"Blumenthal","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi230911r28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamapediatrics.2022.0525","article-title":"The complicated inadequacy of race and ethnicity data.","volume":"176","author":"Chaiyachati","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"7","key":"zoi230911r29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals.","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"zoi230911r31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2105\/AJPH.92.9.1471","article-title":"Self-reported vs administrative race\/ethnicity data and study results.","volume":"92","author":"Boehmer","year":"2002","journal-title":"Am J Public Health"},{"issue":"5","key":"zoi230911r33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s40615-020-00716-8","article-title":"Variability in collection and use of race\/ethnicity and language data in 93 pediatric hospitals.","volume":"7","author":"Cowden","year":"2020","journal-title":"J Racial Ethn Health Disparities"},{"issue":"2","key":"zoi230911r35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1377\/hlthaff.2021.01409","article-title":"The problem of the color line: spatial access to hospital services for minoritized racial and ethnic groups.","volume":"41","author":"Eberth","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"zoi230911r36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.v67.11","article-title":"Diverse populations and enrollment in pediatric cancer clinical trials: challenges and opportunities.","volume":"67","author":"Aristizabal","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"zoi230911r37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1542\/peds.112.4.890","article-title":"Are minority children under- or overrepresented in pediatric research?","volume":"112","author":"Walsh","year":"2003","journal-title":"Pediatrics"},{"issue":"9","key":"zoi230911r38","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00247-022-05460-1","article-title":"Racial and ethnic disparities in pediatric magnetic resonance imaging missed care opportunities.","volume":"52","author":"Shah","year":"2022","journal-title":"Pediatr Radiol"},{"issue":"2","key":"zoi230911r39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1542\/peds.2019-1765","article-title":"The impact of racism on child and adolescent health.","volume":"144","author":"Trent","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"zoi230911r40","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1542\/peds.2014-3109","article-title":"Race, ethnicity, and socioeconomic status in research on child health.","volume":"135","author":"Cheng","year":"2015","journal-title":"Pediatrics"},{"issue":"2","key":"zoi230911r41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.annemergmed.2022.04.003","article-title":"Trends in inequities in the treatment of and outcomes for women and minorities with myocardial infarction.","volume":"80","author":"Montoy","year":"2022","journal-title":"Ann Emerg Med"},{"key":"zoi230911r1","volume-title":"Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups","author":"National Academies of Sciences, Engineering, & Medicine","year":"2022"},{"key":"zoi230911r4","volume-title":"AMA Manual of Style: A Guide for Authors and Editors","author":"JAMA Network"},{"key":"zoi230911r8"},{"key":"zoi230911r30"},{"key":"zoi230911r34","volume-title":"Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care","author":"Smedley","year":"2003"},{"key":"zoi230911r6","unstructured":"National Institutes of Health Revitalization Act of 1993, S 1, 103rd Cong (1993-1994). Accessed February 12, 2023. https:\/\/www.congress.gov\/bill\/103rd-congress\/senate-bill\/1"},{"key":"zoi230911r7","unstructured":"National Institutes of Health. Grants & funding: inclusion of women and minorities as participants in research involving human subjects. Accessed February 12, 2023. https:\/\/grants.nih.gov\/policy\/inclusion\/women-and-minorities.htm"},{"key":"zoi230911r9","unstructured":"National Institutes of Health. Guidance for reporting valid analysis as required by the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research (NOT-OD-18-014). May 4, 2018. Accessed June 22, 2022. https:\/\/grants.nih.gov\/sites\/default\/files\/Valid%20analysis%20CTgov%20guidance%20final_508c.pdf"},{"key":"zoi230911r17","unstructured":"National Institutes of Health. NIH research portfolio online reporting tools. Accessed February 12, 2023. https:\/\/projectreporter.nih.gov\/reporter.cfm"},{"key":"zoi230911r19","unstructured":"National Institutes of Health. Grants & Funding: NIH\u2019s definition of a clinical trial. Accessed February 12, 2023. https:\/\/grants.nih.gov\/policy\/clinical-trials\/definition.htm"},{"key":"zoi230911r20","unstructured":"National Library of Medicine. ClinicalTrials.gov. Accessed February 12, 2023. https:\/\/clinicaltrials.gov\/"},{"key":"zoi230911r21","unstructured":"Institute for Health Metrics and Evaluation. Global Health Data Exchange: search tool. Accessed January 23, 2023. https:\/\/ghdx.healthdata.org\/gbd-results-tool"},{"key":"zoi230911r24","unstructured":"National Institutes of Health. NIH policy on reporting race and ethnicity data: subjects in clinical research. Accessed March 25, 2023. https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/not-od-01-053.html"},{"key":"zoi230911r25","unstructured":"Kids Count Data Center, Annie E. Casey Foundation. Child population by race and ethnicity in United States: 2020. Accessed August 30, 2022. https:\/\/datacenter.kidscount.org\/data\/tables\/103-child-population-by-race#detailed\/1\/any\/false\/574\/68,69,67,12,70,66,71,72\/423,424"},{"key":"zoi230911r26","unstructured":"National Institutes of Health. Participant-level data template tip sheet. Updated October 26, 2022. Accessed September 16, 2022. https:\/\/grants.nih.gov\/sites\/default\/files\/Participant-level%20data%20template%20tip%20sheet.pdf"},{"key":"zoi230911r32","unstructured":"Wynia? M, Hasnain-Wynia? R, Hotze? T, Ivey? SL. Collecting and using race, ethnicity and language data in ambulatory settings: a white paper with recommendations from the Commission to End Health Care Disparites. 2011. Accessed February 12, 2023. https:\/\/www.ama-assn.org\/system\/files\/corp\/media-browser\/public\/health-policy\/cehcd-redata_0.pdf"},{"key":"zoi230911r42","unstructured":"CDC\/ATSDR Social Vulnerability Index. Agency for Toxic Substances and Disease Registry. Accessed March 25, 2023. https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/index.html?"},{"key":"zoi230911r43","unstructured":"diversitydatakids.org. Childhood Opportunity Index. Accessed March 29, 2023. https:\/\/www.diversitydatakids.org\/child-opportunity-index"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2808930\/lee_2023_oi_230911_1692815042.23846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:35:33Z","timestamp":1693395333000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2808930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.31316","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]}}}